ES508670A0 - Procedimiento de preparacion de derivados aminoalcoil heterociclicos farmaceuticamente activos. - Google Patents

Procedimiento de preparacion de derivados aminoalcoil heterociclicos farmaceuticamente activos.

Info

Publication number
ES508670A0
ES508670A0 ES508670A ES508670A ES508670A0 ES 508670 A0 ES508670 A0 ES 508670A0 ES 508670 A ES508670 A ES 508670A ES 508670 A ES508670 A ES 508670A ES 508670 A0 ES508670 A0 ES 508670A0
Authority
ES
Spain
Prior art keywords
aminoalcoyl
cyclic
derivatives
pharmaceutically active
preparation procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES508670A
Other languages
English (en)
Spanish (es)
Other versions
ES8306093A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8027252A external-priority patent/FR2496653A1/fr
Priority claimed from FR8123304A external-priority patent/FR2518087A2/fr
Application filed by Delalande SA filed Critical Delalande SA
Publication of ES8306093A1 publication Critical patent/ES8306093A1/es
Publication of ES508670A0 publication Critical patent/ES508670A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES508670A 1980-12-22 1981-12-21 Procedimiento de preparacion de derivados aminoalcoil heterociclicos farmaceuticamente activos. Granted ES508670A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8027252A FR2496653A1 (fr) 1980-12-22 1980-12-22 Nouveaux derives aminoalcoyl heterocycliques, leurs procedes de preparation et leur application en therapeutique
FR8123304A FR2518087A2 (en) 1981-12-14 1981-12-14 Aminoalkyl di:hydro-naphthalene, isoquinoline and benzoxazepine cpds. - useful as analgesics and antidepressants

Publications (2)

Publication Number Publication Date
ES8306093A1 ES8306093A1 (es) 1983-06-01
ES508670A0 true ES508670A0 (es) 1983-06-01

Family

ID=26222136

Family Applications (3)

Application Number Title Priority Date Filing Date
ES508670A Granted ES508670A0 (es) 1980-12-22 1981-12-21 Procedimiento de preparacion de derivados aminoalcoil heterociclicos farmaceuticamente activos.
ES518692A Expired ES8400093A1 (es) 1980-12-22 1982-12-16 Metodo de preparacion de derivados farmaceuticamente activosaminoalcoil heterociclicos.
ES518693A Granted ES518693A0 (es) 1980-12-22 1982-12-16 Metodo de preparar compuestos aminoalcoil heterociclicos de de actividad farmaceutica.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES518692A Expired ES8400093A1 (es) 1980-12-22 1982-12-16 Metodo de preparacion de derivados farmaceuticamente activosaminoalcoil heterociclicos.
ES518693A Granted ES518693A0 (es) 1980-12-22 1982-12-16 Metodo de preparar compuestos aminoalcoil heterociclicos de de actividad farmaceutica.

Country Status (11)

Country Link
US (3) US4386090A (en])
AU (1) AU7875781A (en])
CA (1) CA1181748A (en])
DE (1) DE3150876A1 (en])
ES (3) ES508670A0 (en])
GB (2) GB2091250B (en])
GR (1) GR78081B (en])
IT (1) IT1168074B (en])
LU (1) LU83850A1 (en])
NL (1) NL8105791A (en])
SE (1) SE8107537L (en])

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3244594A1 (de) * 1982-12-02 1984-06-07 Hoechst Ag, 6230 Frankfurt 1-phenylisochinolinderivate und verfahren zu ihrer herstellung, diese verbindung enthaltende pharmazeutische praeparate und deren anwendung
FR2544718B1 (fr) * 1983-04-21 1985-12-20 Hexachimie Diniflumate d'ester morpholinoethylique d'acide niflumique, preparation, utilisation en therapeutique comme analgesique et anti-inflammatoire
US4745222A (en) * 1983-05-25 1988-05-17 Merrell Dow Pharmaceuticals Inc. Novel aryloxycycloalkanolaminoalkylene aryl ketones
DE3413897A1 (de) * 1984-04-13 1985-10-17 Bayer Ag, 5090 Leverkusen (beta)-naphthylalkylamine
EP0261842B1 (en) * 1986-09-17 1990-11-22 Dr. Lo. Zambeletti S.p.A. N1-acylated-(1-(phenyl or benzyl))-1,2-ethylene diamines
ZA885824B (en) * 1987-08-14 1989-04-26 Merrell Dow Pharma Novel antidepressants
US5149714A (en) * 1987-08-14 1992-09-22 Merrell Dow Pharmaceuticals Inc. Antidepressants
US5561152A (en) * 1987-08-14 1996-10-01 Merrell Pharmaceuticals Inc. Antidepressants
US5229414A (en) * 1988-01-21 1993-07-20 Imperial Chemical Industries Plc Diamine compounds
US5071845A (en) * 1988-12-28 1991-12-10 Suntory Limited Benzoxazepine derivative
US5948820A (en) 1994-08-22 1999-09-07 Yoshitomi Pharmaceutical Industries, Ltd. Benzene compound and pharmaceutical use thereof
IT1303737B1 (it) 1998-11-11 2001-02-23 Smithkline Beecham Spa Derivati fenilpiperidinici procedimento per la loro preparazione eloro uso come ligandi del recettore orl-1.
US6646012B2 (en) * 2001-01-16 2003-11-11 Theravance, Inc. Sodium channel modulators
AU2002344820B2 (en) * 2001-06-20 2006-12-14 Merck & Co., Inc. Dipeptidyl peptidase inhibitors for the treatment of diabetes
WO2003000181A2 (en) * 2001-06-20 2003-01-03 Merck & Co., Inc. Dipeptidyl peptidase inhibitors for the treatment of diabetes
SI1471054T1 (sl) 2002-01-11 2009-12-31 Daiichi Sankyo Co Ltd Amino alkoholni derivati ali derivati fosfoniäśne kisline in medicinski sestavki, ki vsebujejo le-te
CA2490818A1 (en) * 2002-07-15 2004-01-22 Merck & Co., Inc. Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
ATE370141T1 (de) * 2002-10-07 2007-09-15 Merck & Co Inc Antidiabetische heterocyclische beta- aminoverbindungen als inhibitoren von dipeptidylpeptidase
AU2003290577B2 (en) * 2002-11-07 2008-12-11 Merck Sharp & Dohme Corp. Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
US7309714B2 (en) * 2002-12-04 2007-12-18 Merck & Co., Inc. Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
US20060052382A1 (en) * 2002-12-20 2006-03-09 Duffy Joseph L 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
EP1589969A4 (en) * 2003-01-17 2008-08-13 Merck & Co Inc 3-AMINO-4-PHENYLBUTANEAN DERIVATEALS DIPEPTIDYLPEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
AU2004210149A1 (en) * 2003-01-31 2004-08-19 Merck & Co., Inc. 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
CA2524531A1 (en) * 2003-05-14 2004-12-02 Merck And Co., Inc. 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
US7332520B2 (en) * 2003-06-06 2008-02-19 Merck & Co., Inc. Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
EP1638950A4 (en) * 2003-06-17 2010-06-30 Merck Sharp & Dohme CYCLOHEXYLGLYCIN DERIVATIVES AS DIPEPTIDYLPEPTIDASEINHIBITORS FOR THE TREATMENT OF BZW. PREVENTION OF DIABETES
DE602004018503D1 (de) * 2003-07-31 2009-01-29 Merck & Co Inc Hexahydrodiazepinone als inhibitoren des dipeptidylpeptidase-iv zur behandlung bzw. prävention von diabetes
DE602004025132D1 (de) * 2003-09-18 2010-03-04 Takasago Perfumery Co Ltd Asymmetrische reduktive aminierung von ketosäurederivaten zur herstellung von aminosäurederivaten
CN1870990A (zh) * 2003-11-04 2006-11-29 默克公司 作为糖尿病治疗或预防用二肽基肽酶iv抑制剂的稠合苯基丙氨酸衍生物
RU2332212C2 (ru) 2004-02-24 2008-08-27 Санкио Компани, Лимитед Аминоспирт
WO2005108382A1 (en) * 2004-05-04 2005-11-17 Merck & Co., Inc. 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
US7618981B2 (en) * 2004-05-06 2009-11-17 Cytokinetics, Inc. Imidazopyridinyl-benzamide anti-cancer agents
US7504413B2 (en) * 2004-05-06 2009-03-17 Cytokinetics, Inc. N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
US7795448B2 (en) * 2004-05-06 2010-09-14 Cytokinetics, Incorporated Imidazoyl-benzamide anti-cancer agents
EP1604662A1 (en) * 2004-06-08 2005-12-14 Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft 1-[(3R)-Amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2R)-carboxylic acid benzyl amine derivatives and related compounds as dipeptidyl peptidase IV (DPP-IV) inhibitors for the treatment of type 2 diabetes mellitus
WO2007056056A2 (en) * 2005-11-02 2007-05-18 Cytokinetics, Inc. Mitotic kinesin inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2168929A (en) * 1936-12-12 1939-08-08 Winthrop Chem Co Inc Isoquinoline compounds and derivatives thereof
US3663608A (en) * 1969-12-10 1972-05-16 Bristol Myers Co 1-phenyl-3-aminoalkyl-1,2,3,4-tetrahydronaphthalenes and the salts thereof
US3704328A (en) * 1970-01-21 1972-11-28 James S Kaltenbronn 4- and 5-aryl-1-naphthaleneethanol compounds
US3663627A (en) * 1970-06-01 1972-05-16 Bristol Myers Co 1-indanmethanols
GB1400425A (en) * 1971-09-22 1975-07-16 Rolland Sa A Substituted 3-hydroxymethyl-isoquinolines and derivatives
US4022791A (en) * 1975-06-03 1977-05-10 Pfizer Inc. 2-Aminomethyl-3,4-dihydronaphthalenes

Also Published As

Publication number Publication date
CA1181748A (en) 1985-01-29
ES8306093A1 (es) 1983-06-01
GR78081B (en]) 1984-09-26
NL8105791A (nl) 1982-07-16
IT8125722A0 (it) 1981-12-21
ES8400388A1 (es) 1983-11-01
AU7875781A (en) 1982-07-01
US4386090A (en) 1983-05-31
ES518692A0 (es) 1983-11-01
ES518693A0 (es) 1983-11-01
DE3150876A1 (de) 1982-07-29
GB8409163D0 (en) 1984-05-16
GB2091250B (en) 1984-11-14
IT1168074B (it) 1987-05-20
GB2091250A (en) 1982-07-28
US4504663A (en) 1985-03-12
US4431851A (en) 1984-02-14
ES8400093A1 (es) 1983-11-01
GB2137992A (en) 1984-10-17
SE8107537L (sv) 1982-06-23
LU83850A1 (fr) 1983-09-02
GB2137992B (en) 1985-05-09

Similar Documents

Publication Publication Date Title
ES508670A0 (es) Procedimiento de preparacion de derivados aminoalcoil heterociclicos farmaceuticamente activos.
NO810765L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO159166C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzoazepinderivater.
NO853046L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
ES554125A0 (es) Procedimiento de preparar hidroxamatos farmaceuticamente activos.
NO810675L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
FI853649A7 (fi) Menetelmä farmaseuttisesti aktiivisten 2-(pyridyylialkeenisulfinyyli)bentsimidatsolien valmistamiseksi.
FI811525A7 (fi) Menetelmä terapeuttisesti vaikuttavien pyridoksinijohdannaisten valmistamiseksi.
NO831610L (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxicamderivater.
NO900032D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser.
NO802015L (no) Fremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater.
FI831998A7 (fi) Menetelmä farmaseuttisesti aktiivisten pyratsinonijohdannaisten valmistamiseksi.
FI803025A7 (fi) Menetelmä farmakologisesti aktiivisten ergoliinijohdannaisten valmistamiseksi.
FI861006A7 (fi) Menetelmä farmaseuttisesti aktiivisten eetterien valmistamiseksi.
ATE6777T1 (de) Pharmakologisch wirksame tetrapeptid derivate.
ES538649A0 (es) Procedimiento de preparar compuestos tiopiranopirimidinicos farmacologicamente activos.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO822119L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benztriazol-derivater.
ES523695A0 (es) Procedimiento de preparacion de derivados de eburnano-oxima racemicos u opticamente activos.
FI842976A7 (fi) Menetelmä farmaseuttisesti aktiivisten aminopyrimidinonijohdannaisten valmistamiseksi.
NO811360L (no) Fremgangsmaate for fremstilling av terapeutisk aktivt hydratisert picotamid.
NO811134L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-derivater.
FI844374A7 (fi) Menetelmä farmaseuttisesti aktiivisten heterosyklisten yhdisteiden valmistamiseksi.
NO813577L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperdin-derivater.